GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » Selling and Marketing Expense

PharmaCorp Rx (TSXV:PCRX) Selling and Marketing Expense : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PharmaCorp Rx Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. PharmaCorp Rx's Selling and Marketing Expense for the three months ended in Sep. 2024 was C$0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

PharmaCorp Rx Selling and Marketing Expense Historical Data

The historical data trend for PharmaCorp Rx's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCorp Rx Selling and Marketing Expense Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23
Selling and Marketing Expense
- - -

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaCorp Rx Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCorp Rx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » Selling and Marketing Expense
Comparable Companies
XCNQ:AXCP TSXV:XCYT TSXV:THP TSXV:PEZM.H TSXV:RLT.P TSXV:HO.P TSXV:LSC.P TSXV:POC.P TSXV:BAV.H TSXV:KMC.H AACT ANSC EQV AAM NETD CCIX GPAT ALF MBAV IPXX
Traded in Other Exchanges
N/A
Address
303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
Website
PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.